November 5th 2025
The FDA approves a single monthly injection of mirikizumab-mrkz for ulcerative colitis, enhancing patient convenience and addressing bowel urgency effectively.
Less Costly, Patient-Friendly Therapy for Bleeding Ulcers Just as Effective as Standard of Care
May 5th 2014A new study points to the need to revise the current standard of care for patients with bleeding ulcers. Intermittent proton pump therapy is an equally safe, less costly, more comfortable alternative for patients than standard care.